DK0668290T3 - Fysiologisk aktiv substans, som er i stand til at gennemtrænge biomembranen - Google Patents
Fysiologisk aktiv substans, som er i stand til at gennemtrænge biomembranenInfo
- Publication number
- DK0668290T3 DK0668290T3 DK95105215T DK95105215T DK0668290T3 DK 0668290 T3 DK0668290 T3 DK 0668290T3 DK 95105215 T DK95105215 T DK 95105215T DK 95105215 T DK95105215 T DK 95105215T DK 0668290 T3 DK0668290 T3 DK 0668290T3
- Authority
- DK
- Denmark
- Prior art keywords
- biomembrane
- permeating
- active substance
- physiologically active
- substance capable
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
- C07D207/267—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/57—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C233/63—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
- C07K14/70—Enkephalins
- C07K14/702—Enkephalins with at least 1 amino acid in D-form
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/56—Ring systems containing bridged rings
- C07C2603/58—Ring systems containing bridged rings containing three rings
- C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
- C07C2603/74—Adamantanes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP5011690 | 1990-02-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0668290T3 true DK0668290T3 (da) | 1999-07-26 |
Family
ID=12850141
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK91905340.5T DK0516851T3 (da) | 1990-02-28 | 1991-02-27 | Fysiologisk aktiv substans, der er i stand til at gennemtrænge en biomembran |
DK95105215T DK0668290T3 (da) | 1990-02-28 | 1991-02-27 | Fysiologisk aktiv substans, som er i stand til at gennemtrænge biomembranen |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK91905340.5T DK0516851T3 (da) | 1990-02-28 | 1991-02-27 | Fysiologisk aktiv substans, der er i stand til at gennemtrænge en biomembran |
Country Status (5)
Country | Link |
---|---|
EP (2) | EP0516851B1 (da) |
CA (1) | CA2076849A1 (da) |
DE (2) | DE69120397T2 (da) |
DK (2) | DK0516851T3 (da) |
WO (1) | WO1991013081A1 (da) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1264129B1 (it) * | 1993-04-09 | 1996-09-16 | Codev S A | Peptidi ad attivita' immunomodulatoria derivati da frammenti di leucochinina |
US5973128A (en) * | 1996-11-22 | 1999-10-26 | The Hospital For Sick Children Research And Development Lp | Glycolipid mimics and methods of use thereof |
US7880001B2 (en) | 2004-04-29 | 2011-02-01 | Abbott Laboratories | Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme |
US8415354B2 (en) | 2004-04-29 | 2013-04-09 | Abbott Laboratories | Methods of use of inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
US20100222316A1 (en) | 2004-04-29 | 2010-09-02 | Abbott Laboratories | Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
US8198331B2 (en) | 2005-01-05 | 2012-06-12 | Abbott Laboratories | Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
EP2835367A1 (en) | 2005-01-05 | 2015-02-11 | AbbVie Inc. | Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
US20090192198A1 (en) | 2005-01-05 | 2009-07-30 | Abbott Laboratories | Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
NZ555966A (en) | 2005-01-05 | 2011-03-31 | Abbott Lab | Adamantyl derivatives as inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
JP5736098B2 (ja) | 2007-08-21 | 2015-06-17 | アッヴィ・インコーポレイテッド | 中枢神経系障害を治療するための医薬組成物 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SU1179997A1 (ru) * | 1973-02-28 | 1985-09-23 | Ордена Трудового Красного Знамени Институт Органического Синтеза Ан Латсср | Средство дл лечени паркинсонизма "глудантан |
JPS5143769A (en) * | 1974-10-14 | 1976-04-14 | Asahi Chemical Ind | 11 beeta dd arabinofuranoshirushitoshinjudotaino seizoho |
JPS5919557B2 (ja) * | 1979-05-02 | 1984-05-07 | ヤマサ醤油株式会社 | N↑6−置換コルジセピン誘導体およびその製造法 |
US4273704A (en) * | 1979-12-03 | 1981-06-16 | G. D. Searle & Co. | N-Adamantane-substituted tetrapeptide amides |
FR2572399B1 (fr) * | 1984-10-31 | 1987-01-16 | Panmedica Sa | Nouveaux derives de l'adamantanamine, leurs procedes de preparation et medicaments les contenant |
NO170884C (no) * | 1986-08-18 | 1992-12-23 | Hoffmann La Roche | Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrimidinderivater |
JPH0717655B2 (ja) * | 1987-05-27 | 1995-03-01 | 三共株式会社 | 経口用セフアロスポリン化合物 |
-
1991
- 1991-02-27 CA CA002076849A patent/CA2076849A1/en not_active Abandoned
- 1991-02-27 WO PCT/JP1991/000256 patent/WO1991013081A1/ja active IP Right Grant
- 1991-02-27 DE DE69120397T patent/DE69120397T2/de not_active Expired - Fee Related
- 1991-02-27 EP EP91905340A patent/EP0516851B1/en not_active Expired - Lifetime
- 1991-02-27 DE DE69130489T patent/DE69130489T2/de not_active Expired - Fee Related
- 1991-02-27 EP EP95105215A patent/EP0668290B1/en not_active Expired - Lifetime
- 1991-02-27 DK DK91905340.5T patent/DK0516851T3/da active
- 1991-02-27 DK DK95105215T patent/DK0668290T3/da active
Also Published As
Publication number | Publication date |
---|---|
DE69130489T2 (de) | 1999-05-12 |
DE69120397T2 (de) | 1996-11-07 |
EP0668290B1 (en) | 1998-11-11 |
WO1991013081A1 (fr) | 1991-09-05 |
EP0516851A1 (en) | 1992-12-09 |
EP0668290A1 (en) | 1995-08-23 |
DE69120397D1 (de) | 1996-07-25 |
CA2076849A1 (en) | 1991-08-29 |
DE69130489D1 (de) | 1998-12-17 |
DK0516851T3 (da) | 1996-07-15 |
EP0516851A4 (en) | 1993-06-09 |
EP0516851B1 (en) | 1996-06-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI925615A0 (fi) | Stabiliserade farmaceutiska kompositioner, som innehaoller en hmg-coa-reduktas-inhibitorfoerening | |
ATE98480T1 (de) | Arzneimittelformulierungen. | |
MX9200180A (es) | DERIVADOS DE LA 5H-PIRROL (3,4-b) PIRAZINA OPTICAMENTE ACTIVOS, PROCEDIMIENTO PARA SU PREPARACION Y COMPOSICION FARMACEUTICA QUE LOS CONTIENE. | |
NO874873L (no) | Anordning for autoadministrering av fysiologisk aktive stoffer, med forhindring av overdosering. | |
FI910851A0 (fi) | 3-arylkarbonyl-1h-indoler anvaendbara som terapeutiska aemnen. | |
FI925778A (fi) | Farmaceutiskt aktiva bensokinazolinfoereningar | |
FI891227A (fi) | Katekolderivat och farmaceutiska preparat som innehaoller dessa. | |
DK0668290T3 (da) | Fysiologisk aktiv substans, som er i stand til at gennemtrænge biomembranen | |
MX9204635A (es) | Procedimiento para la preparacion de derivados de beta-fenilisoserina. | |
FI890853A (fi) | Farmaceutiskt preparat som tryggar transdermal absorption av den aktiva bestaondsdelen och foerfarande foer framstaellning daerav. | |
FI864164A0 (fi) | Biologiskt aktiva derivat av human- -interferon, deras framstaellning och laekemedel, som innehaoller dylika derivat. | |
FI884545A0 (fi) | Farmaceutisk komposition, som innehaoller avsvaellande piperidinoalkanolfoereningar. | |
IT8722501A0 (it) | Formulazioni farmaceutiche per somministrazione transdermica. | |
DK0469440T3 (da) | Faste orale applikationsformer, der som aktivt stof indeholder ifosamid | |
DK166352C (da) | Azolylmethylcyclopentanderivat, fremgangsmaade til fremstilling heraf samt landbrugsmaessigt/havebrugsmaessigt fungicid indeholdende derivatet som aktiv bestanddel | |
NO910022D0 (no) | Fungiside virkestoffkombinasjoner. | |
FI923371A0 (fi) | En farmaceutisk formulation. | |
FI894072A (fi) | Polypeptider anvaendbara som vaccin. | |
CL2004000486A1 (es) | Compuestos de (piridinil amino)-bencisoxazol y bencisotiazol substituidos, la composicion farmaceutica que los contiene, su procedimiento de preparacion a partir de un bencisoxazol o bencisotiazol y su uso como farmaco con actividad antidepresiva. | |
DK256689A (da) | 1,2-dithiol-3-thion-s-oxid-forbindelser til anven delse som laegemidler | |
MX9202987A (es) | Analogos de insulina, formulacion farmaceutica que los contiene y procedimiento para obtener dichos analogos. | |
FI883738A0 (fi) | Substituerade tienoimidazolderivat, foerfarande foer deras framstaellning, dessa innehaollande farmaceutiska produkter och deras anvaendning som magsyrasekret haemmande medel. | |
DE68908838D1 (de) | Pharmazeutisch wirksame Dithioketen-Derivaten. | |
DK162631C (da) | Forbindelse, betegnet fr-900216, til anvendelse som terapeutisk aktivt stof, farmaceutisk praeparat indeholdende forbindelsen samt anvendelse af forbindelsen | |
DK170491A (da) | Oxo-ionolcarbonater anvendelige som tobaksaromastoffer |